| Intro • Projets • Publications |

Formation

à venir

Axe principal

Transfert des connaissances et évaluation des technologies et des modes d'intervention en santé

Adresse

10, rue de l'Espinay, A2-222
Québec (Québec)
CANADA G1L 3L5

Téléphone

+1 418-525-4470

Télécopieur

+1 418-525-4195

Courriel

francois.rousseau@mac.com

Projet(s) de recherche actif(s)

Publications récentes (voir toutes les publications de ce chercheur)

Rousseau F, Pan B, Fairbrother WJ, Bazan JF, Lingel A. The structure of the extracellular domain of the jumping translocation breakpoint protein reveals a variation of the midkine fold. Journal of molecular biology,  2012. 415: 22-8

Legare F, St-Jacques S, Gagnon S, Njoya M, Brisson M, Fremont P, Rousseau F. Prenatal screening for Down syndrome: a survey of willingness in women and family physicians to engage in shared decision-making. Prenatal diagnosis,  2011. 31: 319-26

Giguere A, Legare F, Grad R, Pluye P, Rousseau F, Haynes RB, Cauchon M, Labrecque M. Developing and user-testing Decision boxes to facilitate shared decision making in primary care--a study protocol. BMC medical informatics and decision making,  2011. 11: 17

Girard C, Simard M, Noiseux R, Laplante L, Dugas M, Rousseau F, Gagnon N, Primeau F, Keller E, Bernier PJ. Late-onset-psychosis: cognition. International psychogeriatrics / IPA,  2011. 23: 1301-16

Gekas J, Durand A, Bujold E, Vallee M, Forest JC, Rousseau F, Reinharz D. Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used? American journal of obstetrics and gynecology,  2011. 204: 175.e1-8

Ferron M, Boudiffa M, Arsenault M, Rached M, Pata M, Giroux S, Elfassihi L, Kisseleva M, Majerus PW, Rousseau F, Vacher J. Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans. Cell metabolism,  2011. 14: 466-77

Rousseau F, Labelle Y, Bussieres J, Lindsay C. The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge. The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists,  2011. 32: 135-62

Giguere Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, Lafond J, Legare F, Forest JC. [Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review]. Annales de biologie clinique,  2011. 69: 257-71

Giroux S, Bussieres J, Bureau A, Rousseau F. UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,  2011. Epub

Giguere Y, Charland M, Theriault S, Bujold E, Laroche M, Rousseau F, Lafond J, Forest JC. Review: Linking preeclampsia and cardiovascular disease later in life. Clinical chemistry and laboratory medicine : CCLM / FESCC,  2011. Epub